Rare diseases
Investigational molecules
Locations
Back to Germany9 clinical trials in Neuenhagen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
GermanyTesting benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for relief of sore throat symptoms in patients with acute pharyngitis
GermanyStudy on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen
GermanyStudy of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms
GermanyStudy on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis
GermanyStudy on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy
GermanyDose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis
GermanyStudy on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma
GermanyStudy on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on developing treatments for seasonal allergic rhinitis and rhinoconjunctivitis caused by grass and birch pollen exposure. Investigations include innovative immunotherapy approaches for both pediatric and adult populations.
Research aims to evaluate long-term effectiveness of immunotherapy treatments in reducing allergy symptoms.
Comprehensive research on allergic rhinoconjunctivitis treatments, including studies of subcutaneous immunotherapy options. Special focus on moderate to severe cases, including patients with concurrent asthma symptoms.
Trials evaluate both immediate symptom relief and long-term therapeutic benefits.
Advanced clinical investigations of mannan-conjugated allergoids and other novel immunotherapy approaches. Studies include double-blind placebo-controlled trials to ensure reliable efficacy assessment.
Research focuses on developing more effective and targeted allergy treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
